WO2019004768A2 - Composition cosmétique et son procédé de préparation - Google Patents
Composition cosmétique et son procédé de préparation Download PDFInfo
- Publication number
- WO2019004768A2 WO2019004768A2 PCT/KR2018/007391 KR2018007391W WO2019004768A2 WO 2019004768 A2 WO2019004768 A2 WO 2019004768A2 KR 2018007391 W KR2018007391 W KR 2018007391W WO 2019004768 A2 WO2019004768 A2 WO 2019004768A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stearate
- cosmetic composition
- group
- adenosine
- inorganic powder
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 72
- 239000002537 cosmetic Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title description 2
- 239000004480 active ingredient Substances 0.000 claims abstract description 42
- 239000000843 powder Substances 0.000 claims abstract description 42
- 239000003381 stabilizer Substances 0.000 claims abstract description 37
- 229910052751 metal Inorganic materials 0.000 claims abstract description 27
- 239000002184 metal Substances 0.000 claims abstract description 27
- 239000002270 dispersing agent Substances 0.000 claims abstract description 15
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 claims description 87
- 239000002126 C01EB10 - Adenosine Substances 0.000 claims description 54
- 229960005305 adenosine Drugs 0.000 claims description 54
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 40
- 239000011570 nicotinamide Substances 0.000 claims description 40
- 229960003966 nicotinamide Drugs 0.000 claims description 40
- 235000005152 nicotinamide Nutrition 0.000 claims description 40
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 24
- 229960005323 phenoxyethanol Drugs 0.000 claims description 24
- -1 polyoxyethylene glycerylisostearate Polymers 0.000 claims description 16
- 238000000034 method Methods 0.000 claims description 15
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 claims description 14
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 14
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical group O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 14
- 229940050410 gluconate Drugs 0.000 claims description 14
- 239000011575 calcium Substances 0.000 claims description 12
- 239000011777 magnesium Substances 0.000 claims description 12
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 12
- 239000003945 anionic surfactant Substances 0.000 claims description 11
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 8
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims description 7
- AFWTZXXDGQBIKW-UHFFFAOYSA-N C14 surfactin Natural products CCCCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 AFWTZXXDGQBIKW-UHFFFAOYSA-N 0.000 claims description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 7
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 claims description 7
- 229940075529 glyceryl stearate Drugs 0.000 claims description 7
- 239000000395 magnesium oxide Substances 0.000 claims description 7
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 7
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 7
- 239000003002 pH adjusting agent Substances 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- 229950011392 sorbitan stearate Drugs 0.000 claims description 7
- NJGWOFRZMQRKHT-UHFFFAOYSA-N surfactin Natural products CC(C)CCCCCCCCCC1CC(=O)NC(CCC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C(C)C)C(=O)NC(CC(O)=O)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-UHFFFAOYSA-N 0.000 claims description 7
- NJGWOFRZMQRKHT-WGVNQGGSSA-N surfactin C Chemical compound CC(C)CCCCCCCCC[C@@H]1CC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)O1 NJGWOFRZMQRKHT-WGVNQGGSSA-N 0.000 claims description 7
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 claims description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 6
- 229940009098 aspartate Drugs 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- ZUVCYFMOHFTGDM-UHFFFAOYSA-N hexadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCOP(O)(O)=O ZUVCYFMOHFTGDM-UHFFFAOYSA-N 0.000 claims description 6
- 229910052749 magnesium Inorganic materials 0.000 claims description 6
- 229940091250 magnesium supplement Drugs 0.000 claims description 6
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 6
- NKEQOUMMGPBKMM-UHFFFAOYSA-N 2-hydroxy-2-[2-(2-hydroxy-3-octadecanoyloxypropoxy)-2-oxoethyl]butanedioic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)COC(=O)CC(O)(C(O)=O)CC(O)=O NKEQOUMMGPBKMM-UHFFFAOYSA-N 0.000 claims description 5
- LBPNCQGSZHRGME-UHFFFAOYSA-N 2,2,3,3,4,4-hexahydroxyoctadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)(O)C(O)(O)C(O)(O)C(O)=O LBPNCQGSZHRGME-UHFFFAOYSA-N 0.000 claims description 4
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 claims description 4
- 229910000420 cerium oxide Inorganic materials 0.000 claims description 4
- 229960002989 glutamic acid Drugs 0.000 claims description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 229960001679 octinoxate Drugs 0.000 claims description 4
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 claims description 4
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 3
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 claims description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 claims description 3
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 3
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 3
- 239000005642 Oleic acid Substances 0.000 claims description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 3
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- 229910010413 TiO 2 Inorganic materials 0.000 claims description 3
- 238000006482 condensation reaction Methods 0.000 claims description 3
- 229910052802 copper Inorganic materials 0.000 claims description 3
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 3
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 3
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100460 peg-100 stearate Drugs 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 229960004889 salicylic acid Drugs 0.000 claims description 3
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 3
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 2
- 229960005069 calcium Drugs 0.000 claims description 2
- 235000011478 zinc gluconate Nutrition 0.000 claims description 2
- 239000011670 zinc gluconate Substances 0.000 claims description 2
- 229960000306 zinc gluconate Drugs 0.000 claims description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- 229960004106 citric acid Drugs 0.000 claims 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 229960000448 lactic acid Drugs 0.000 claims 1
- 229940070765 laurate Drugs 0.000 claims 1
- 239000006185 dispersion Substances 0.000 abstract description 15
- 238000009827 uniform distribution Methods 0.000 abstract description 8
- 238000001179 sorption measurement Methods 0.000 abstract description 3
- 150000001450 anions Chemical class 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
- 230000000052 comparative effect Effects 0.000 description 13
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 8
- 229920001223 polyethylene glycol Polymers 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 239000002202 Polyethylene glycol Substances 0.000 description 6
- 229940074046 glyceryl laurate Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- ARIWANIATODDMH-UHFFFAOYSA-N rac-1-monolauroylglycerol Chemical compound CCCCCCCCCCCC(=O)OCC(O)CO ARIWANIATODDMH-UHFFFAOYSA-N 0.000 description 5
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 229940108925 copper gluconate Drugs 0.000 description 4
- 229940008099 dimethicone Drugs 0.000 description 4
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 4
- 239000004205 dimethyl polysiloxane Substances 0.000 description 4
- 229940074052 glyceryl isostearate Drugs 0.000 description 4
- 229940049294 glyceryl stearate se Drugs 0.000 description 4
- 229960001983 magnesium aspartate Drugs 0.000 description 4
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 4
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- 239000011787 zinc oxide Substances 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000010419 fine particle Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 241001237961 Amanita rubescens Species 0.000 description 2
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 2
- 229940063655 aluminum stearate Drugs 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 229940078456 calcium stearate Drugs 0.000 description 2
- 235000013539 calcium stearate Nutrition 0.000 description 2
- 239000008116 calcium stearate Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- DMBUODUULYCPAK-UHFFFAOYSA-N 1,3-bis(docosanoyloxy)propan-2-yl docosanoate Chemical compound CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCCCCCC DMBUODUULYCPAK-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- KZEVSDGEBAJOTK-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[5-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CC=1OC(=NN=1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O KZEVSDGEBAJOTK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- VWVRASTUFJRTHW-UHFFFAOYSA-N 2-[3-(azetidin-3-yloxy)-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound O=C(CN1C=C(C(OC2CNC2)=N1)C1=CN=C(NC2CC3=C(C2)C=CC=C3)N=C1)N1CCC2=C(C1)N=NN2 VWVRASTUFJRTHW-UHFFFAOYSA-N 0.000 description 1
- SXAMGRAIZSSWIH-UHFFFAOYSA-N 2-[3-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,2,4-oxadiazol-5-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NOC(=N1)CC(=O)N1CC2=C(CC1)NN=N2 SXAMGRAIZSSWIH-UHFFFAOYSA-N 0.000 description 1
- XXZCIYUJYUESMD-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-(morpholin-4-ylmethyl)pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CN1CCOCC1 XXZCIYUJYUESMD-UHFFFAOYSA-N 0.000 description 1
- WWSJZGAPAVMETJ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethoxypyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)OCC WWSJZGAPAVMETJ-UHFFFAOYSA-N 0.000 description 1
- LPZOCVVDSHQFST-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-3-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C(=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2)CC LPZOCVVDSHQFST-UHFFFAOYSA-N 0.000 description 1
- FYELSNVLZVIGTI-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-5-ethylpyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1CC)CC(=O)N1CC2=C(CC1)NN=N2 FYELSNVLZVIGTI-UHFFFAOYSA-N 0.000 description 1
- WZFUQSJFWNHZHM-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 WZFUQSJFWNHZHM-UHFFFAOYSA-N 0.000 description 1
- JQMFQLVAJGZSQS-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JQMFQLVAJGZSQS-UHFFFAOYSA-N 0.000 description 1
- IHCCLXNEEPMSIO-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)CC(=O)N1CC2=C(CC1)NN=N2 IHCCLXNEEPMSIO-UHFFFAOYSA-N 0.000 description 1
- ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)N1CC2=C(CC1)NN=N2 ZRPAUEVGEGEPFQ-UHFFFAOYSA-N 0.000 description 1
- JVKRKMWZYMKVTQ-UHFFFAOYSA-N 2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C=1C=NN(C=1)CC(=O)NC1=CC2=C(NC(O2)=O)C=C1 JVKRKMWZYMKVTQ-UHFFFAOYSA-N 0.000 description 1
- YJLUBHOZZTYQIP-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)NN=N2 YJLUBHOZZTYQIP-UHFFFAOYSA-N 0.000 description 1
- PKKRBIGEOKIMOY-UHFFFAOYSA-N 2-methoxy-3-phenylnon-2-enoic acid Chemical compound CCCCCCC(=C(OC)C(O)=O)C1=CC=CC=C1 PKKRBIGEOKIMOY-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- CONKBQPVFMXDOV-QHCPKHFHSA-N 6-[(5S)-5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-2-oxo-1,3-oxazolidin-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C[C@H]1CN(C(O1)=O)C1=CC2=C(NC(O2)=O)C=C1 CONKBQPVFMXDOV-QHCPKHFHSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-PWCQTSIFSA-N Tritiated water Chemical compound [3H]O[3H] XLYOFNOQVPJJNP-PWCQTSIFSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 238000000889 atomisation Methods 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 229940102552 disteardimonium hectorite Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- JBKVHLHDHHXQEQ-UHFFFAOYSA-N epsilon-caprolactam Chemical class O=C1CCCCCN1 JBKVHLHDHHXQEQ-UHFFFAOYSA-N 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- UQEAIHBTYFGYIE-UHFFFAOYSA-N hexamethyldisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)C UQEAIHBTYFGYIE-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000010954 inorganic particle Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N phenyl acetate Chemical compound CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 229940100552 retinamide Drugs 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 229940098780 tribehenin Drugs 0.000 description 1
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 1
- UUJLHYCIMQOUKC-UHFFFAOYSA-N trimethyl-[oxo(trimethylsilylperoxy)silyl]peroxysilane Chemical compound C[Si](C)(C)OO[Si](=O)OO[Si](C)(C)C UUJLHYCIMQOUKC-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/39—Derivatives containing from 2 to 10 oxyalkylene groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention relates to a cosmetic composition, and more particularly, to a cosmetic composition which stably exhibits excellent stability and excellent makeup effect.
- inorganic particles such as titanium dioxide and zinc oxide have fine particles having a size of micron or less contained in the cosmetic composition
- UV-A, B ultraviolet spectroscopy
- titanium dioxide, zinc oxide, zinc oxide, titanium oxide, iron oxide, magnesium oxide, and the like are known as materials having physical properties for reflecting and dispersing ultraviolet rays.
- the inorganic powder has a wide surface area (m 2 / g) and a surface charge due to atomization. Particularly when the surface modification is insufficient, adenosine, niacinamide, Such as hexylmethoxycinnamate, are adsorbed on the inorganic powder, and as a result, the amount of the functional active ingredient contained in the cosmetic composition is reduced.
- the applicant of the present invention found that when a cosmetic composition is used with a metal dispersant, an anionic surfactant, a pH adjuster, or the like in combination with an inorganic powder, the functional active ingredients are prevented from being adsorbed to the inorganic powder, It is possible to maintain an even distribution of
- an object of the present invention is to provide a cosmetic composition which can prevent dispersion of functional active ingredients in inorganic powder while maintaining dispersion stability and uniform distribution in skin.
- the present invention provides an inorganic powder; At least one stabilizer selected from the group consisting of metal dispersants, anionic surfactants and pH adjusters; And a functional active ingredient.
- the metal dispersant may be at least one selected from the group consisting of a Gluconate-based metal salt, a Stearate-based metal salt, an Aspartate-based metal salt, and a Cetyl Phosphate-based metal salt have.
- the metal dispersant may be at least one selected from the group consisting of copper (Cu) gluconate, calcium (Ca) gluconate, zinc gluconate, calcium (Ca) stearate, magnesium (Mg) stearate, At least one selected from the group consisting of aluminum (Al) stearate, magnesium (Mg) aspartate, and potassium (K) cetyl phosphate.
- the anionic surfactant may be selected from the group consisting of glyceryl stearate citrate, sodium surfactin, polyoxyethylene glycerylisostearate, PEG-20 glyceryl tri Glyceryl triisostearate, polyethylene glycol monoisostearate, PEG-100 stearate, PEG-40 stearate, sorbitan stearate, glyceryl stearate, At least one selected from the group consisting of glyceryl laurate, glyceryl stearate and hexahydroxystearate may be used.
- the pH adjusting agent may be selected from the group consisting of L-glutamic acid, Lactic Acid, CITRIC ACID, SALICYLIC ACID, MYRISTIC ACID, Oleic acid and lauric acid (LAURIC ACID). ≪ Desc / Clms Page number 7 >
- the inorganic powder may be at least one selected from the group consisting of titania (TiO 2 ), zinc oxide (ZnO), iron oxide (Fe 2 O 3, FeO, Fe 3 O 4), magnesium oxide (MgO), manganese oxide (MnO 2) and cerium oxide , ≪ / RTI >
- the functional active ingredient may be at least one selected from the group consisting of adenosine, niacinamide, phenoxyethanol, and ethylhexylmethoxycinnamate.
- the inorganic powder and the stabilizer may be contained in a ratio of 100: 1 to 10: 1.
- the inorganic powder may be contained in an amount of 1 to 10% by weight based on the whole composition.
- the stabilizer may be contained in an amount of 0.05 to 1.0% by weight based on the whole composition.
- some of the stabilizers may be bonded to the OH groups on the surface of the inorganic powder or may be bonded by a condensation reaction.
- the cosmetic composition can be used for a cosmetic composition for skin care or a cosmetic composition for make-up.
- a cosmetic composition capable of stably incorporating functional ingredients into the composition can be prepared.
- products having both dispersion stability and uniform distribution on the skin may be products such as a cosmetic composition for skin care or a cosmetic composition for make-up, and the preference for these products can be improved.
- the present invention provides a cosmetic composition capable of preventing dispersion of functional active ingredients in inorganic powder while maintaining dispersion stability and uniform distribution in skin, At least one stabilizer selected from the group consisting of metal dispersants, anionic surfactants and pH adjusters; And a functional active ingredient.
- inorganic fine particles such as titanium dioxide or zinc oxide
- a large surface area m 2 / g
- functional active substances such as adenosine, niacinamide, phenoxyethanone, ethylhexylmethoxycinnamate and the like is adsorbed to the inorganic powder, resulting in a decrease in the content of the functional active ingredient contained in the cosmetic composition .
- the present invention uses a stabilizer such as a metal dispersant, an anionic surfactant, and a pH adjuster together with an inorganic powder to prevent dispersion of the functional active ingredients in the inorganic powder while maintaining dispersion stability and uniform distribution in the skin
- a stabilizer such as a metal dispersant, an anionic surfactant, and a pH adjuster
- the present invention relates to a technique for implementing a cosmetic composition which can be used as a cosmetic composition. With this technology, there is a ripple effect that the amount of the functional active ingredient contained in the cosmetic composition, which is a characteristic of the product, can be stably maintained in the customer.
- the inorganic powder to be contained in the cosmetic composition of the present invention is not particularly limited as long as it is an inorganic powder having a size (particle diameter) of not more than micron ( ⁇ ), but preferably TiO 2 , Iron oxide (Fe2O3, FeO, Fe3O4), magnesium oxide (MgO), manganese oxide (MnO2) and cerium oxide (CeO).
- the inorganic powder may be contained in an amount of 0.1 to 25% by weight, preferably 0.5 to 15% by weight, more preferably 1 to 10% by weight based on the whole composition.
- the inorganic substance is contained in an amount of less than 0.1% by weight, the effect of ultraviolet ray shielding is insignificant, and when it is used in an amount of 25% by weight or more, it is unsuitable for cosmetics.
- cosmetically suitable means that when these substances are applied to the skin, it is not pleasant due to a feeling of hunger, which leads to discomfort, and the appearance of whitening of the skin due to whitening on the skin means bad appearance.
- the stabilizer contained in the cosmetic composition of the present invention may be at least one selected from the group consisting of a metal dispersant, an anionic surfactant, and a pH adjuster.
- the stabilizer may be contained in an amount of 0.05 to 20.0% by weight, preferably 0.1 to 5% by weight, based on the entire composition.
- the functional active ingredient can not be prevented from adsorbing to the inorganic powder. Therefore, there is a problem with the stability of the functional active ingredient.
- the content is more than 20% by weight, Which is undesirable.
- the metal dispersant at least one selected from the group consisting of a Gluconate-based metal salt, a Stearate-based metal salt, an Aspartate-based metal salt, a Cetyl Phosphate-based metal salt, And more specifically copper (Cu) gluconate, calcium (Ca) gluconate, zinc (Zn) gluconate, calcium (Ca) stearate, magnesium (Mg) stearate, zinc (Al) stearate, magnesium (Mg) aspartate, potassium (K) cetyl phosphate, and the like.
- a Gluconate-based metal salt a Stearate-based metal salt
- an Aspartate-based metal salt a Cetyl Phosphate-based metal salt
- anionic surfactant examples include glyceryl stearate citrate, sodium surfactin, polyoxyethylene glycerylisostearate, PEG-20 glyceryl triisostearate, Glyceryl triisostearate, polyethylene glycol monoisostearate, PEG-100 stearate, PEG-40 stearate, sorbitan stearate, glyceryl laurate ( glyceryl stearate, glyceryl laurate, glyceryl stearate, and hexahydroxystearate may be used.
- pH adjuster examples include L-glutamic acid, Lactic Acid, CITRIC ACID, SALICYLIC ACID, MYRISTIC ACID, Oleic acid and lauric acid (LAURIC ACID) may be used.
- All or a part of the stabilizer can be combined with the OH group on the surface of the inorganic powder, or can be combined with a condensation reaction or an ionic bond (in the case of a metal dispersant) to prevent the functional active ingredient from being adsorbed on the inorganic powder.
- a condensation reaction or an ionic bond in the case of a metal dispersant
- the amount of the functional active ingredient substantially present in the cosmetic composition can be increased. Accordingly, the functional active ingredient adsorbed to the inorganic powder can be minimized over time, and even if the cosmetic composition is used for a long period of time, the functional active ingredient can be stably contained.
- the inorganic powder and the stabilizer may be contained in a ratio of 100: 1 to 10: 1 (inorganic powder: stabilizer).
- the ratio of the inorganic powder to the stabilizer is more than 100: 1, the stabilizer does not sufficiently react with the inorganic powder, so that the adsorption of the functional active ingredient can not be prevented.
- the ratio is less than 10: 1, Is too low.
- an anionic surfactant or a metal dispersant there is a problem such as skin irritation and the like, which is not preferable.
- the functional active ingredient contained in the cosmetic composition of the present invention may be at least one selected from the group consisting of adenosine, niacinamide, phenoxyethanol, and ethylhexylmethoxycinnamate.
- the functional active ingredient may be used in various compositions and contents depending on the user's intention.
- adenosine is 0.04% as a wrinkle-functioning ingredient in functional cosmetics based on the whole composition
- niacinamide is a whitening functional ingredient
- Arbutin was 2.00% in raw material content of functional cosmetics, 2.00% in raw whitening functional ingredient in functional cosmetics, and 7.7% in ethoxylated caprolactam, Can legally use up to 1%.
- the cosmetic composition of the present invention may further comprise ingredients used in conventional cosmetic compositions in addition to the above-mentioned composition.
- the additional components are not particularly limited, but may further include a mulberry extract, a useful licorice extract, retinyl palmitate, polyethoxylated retinamide, ascorbyl glucoside, magnesium ascorbyl phosphate and the like.
- the cosmetic composition of the present invention can be used in a cosmetic product that can maintain dispersion stability and uniform distribution on the skin.
- the cosmetic composition includes both a cosmetic composition for skin care or a cosmetic composition for make-up, and specifically includes a makeup primer, A makeup base, a liquid or solid foundation, a foundation, a powder, a twin cake, a lipstick, a lip gloss, an eye shadow, an eyebrow, a concealer, a lip liner, a blusher, , Powder, twin cakes, lipstick, lip gloss, eye shadow, eyebrow, concealer or blusher.
- the present invention also provides a method for producing a cosmetic composition
- the content of the inorganic powder, the stabilizer and the functional active ingredient in the method for producing the cosmetic composition is the same as that described in the cosmetic composition of the present invention.
- a cosmetic composition was prepared by mixing the oil component and the water component in Table 1 with an inorganic powder, a stabilizer and a functional active ingredient.
- stabilizers and functional active ingredient As the stabilizer and the functional active ingredient, stabilizers and functional active ingredients as shown in Tables 2 to 3 below were used.
- the specific manufacturing method is as follows.
- Example 1 Copper Gluconate 97.7% 98.8% 99.4%
- Example 2 Calsium Gluconate 97.3% 98.4% 99.5%
- Example 3 Calcium-stearate 99.3% 100% 99.9%
- Example 4 ALUMINUM stearate 97.2% 98.5% 98.0%
- Example 7 POLYOXYETHYLENE GLYCERYL ISOSTEARATE 99.5% 100% 98.9%
- Example 8 SODIUM SURFACTIN 96.2% 99.2% 99.1%
- Example 9 PEG-20 Glyceryl Triisostearate 97.4% 99.4% 99.5%
- Example 10 POLYETHYLENE G
- the functional active ingredient was not adsorbed to the inorganic powder even after prolonged time, and that the functional active ingredient could be stably contained.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
La présente invention concerne une composition cosmétique contenant : une poudre inorganique ; au moins un stabilisant choisi dans le groupe constitué par un dispersant métallique, un tensioactif anionique et un agent d'ajustement de pH ; et des substances actives fonctionnelles. La composition cosmétique selon la présente invention peut empêcher l'adsorption des substances actives fonctionnelles sur la poudre inorganique tout en maintenant la stabilité de dispersion et une distribution uniforme sur la peau.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201880056549.9A CN111050732A (zh) | 2017-06-30 | 2018-06-29 | 化妆品组合物及其制备方法 |
CA3068205A CA3068205A1 (fr) | 2017-06-30 | 2018-06-29 | Composition cosmetique et son procede de preparation |
US16/627,025 US20200113795A1 (en) | 2017-06-30 | 2018-06-29 | Cosmetic composition and preparation method therefor |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20170083089 | 2017-06-30 | ||
KR10-2017-0083089 | 2017-06-30 | ||
KR10-2018-0073391 | 2018-06-26 | ||
KR1020180073391A KR102552133B1 (ko) | 2017-06-30 | 2018-06-26 | 화장료 조성물 및 이의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2019004768A2 true WO2019004768A2 (fr) | 2019-01-03 |
WO2019004768A3 WO2019004768A3 (fr) | 2019-02-21 |
Family
ID=64741797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2018/007391 WO2019004768A2 (fr) | 2017-06-30 | 2018-06-29 | Composition cosmétique et son procédé de préparation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2019004768A2 (fr) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5113755B2 (ja) * | 2005-09-23 | 2013-01-09 | ディーエスエム アイピー アセッツ ビー.ブイ. | ヒドロキシ脂肪酸を含む化粧品組成物 |
EP2129360A1 (fr) * | 2007-03-23 | 2009-12-09 | Basf Se | Procédé de fabrication d'oxydes métalliques, hydroxydes métalliques et/ou oxydes-hydroxydes métalliques nanoparticulaires, modifiés en surface |
JP6114083B2 (ja) * | 2012-03-26 | 2017-04-12 | 株式会社コーセー | 油中水型固形化粧料 |
KR102048752B1 (ko) * | 2012-12-26 | 2019-11-26 | 미요시 가세이 가부시키가이샤 | 표면처리 분체 및 이를 배합한 화장료 |
KR101551370B1 (ko) * | 2013-07-23 | 2015-09-09 | 주식회사 서울화장품 | 스폰지 폼에 함침시켜 제조하는 자외선 차단용 화장품 |
-
2018
- 2018-06-29 WO PCT/KR2018/007391 patent/WO2019004768A2/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2019004768A3 (fr) | 2019-02-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20080213322A1 (en) | Method for the hydrophobic treatment of pigment particles and the personal care compositions comprising said pigment particles | |
CN118078649A (zh) | 微胶囊及其制备方法与包含多个微胶囊的非化妆品组合物 | |
WO1993020150A1 (fr) | Produit cosmetique nouveau | |
JP2014019689A (ja) | 水素発生用粉末 | |
EP1329211A1 (fr) | Resine antibacterienne | |
JPH10139647A (ja) | 粉末化粧品組成物 | |
JP2686484B2 (ja) | 紫外線吸収剤内包マイクロカプセル及びその製造方法並びにそのマイクロカプセルを含有する化粧料 | |
US8425941B2 (en) | Powder cosmetic composition | |
WO2018052260A1 (fr) | Composition cosmétique de maquillage contenant de la poudre de scories | |
EP3548144B1 (fr) | Composition cosmétique pulvérulente comprenant de la cellulose nanocristalline | |
KR102552133B1 (ko) | 화장료 조성물 및 이의 제조방법 | |
EP3636247A1 (fr) | Agent de modification de poudre, poudre composite et produit cosmétique de maquillage | |
WO2019004768A2 (fr) | Composition cosmétique et son procédé de préparation | |
WO2023054898A1 (fr) | Composition cosmétique dispersée dans de l'huile comprenant un oxyde inorganique à surface modifiée comportant un dérivé d'acide aminé | |
JP2000159632A (ja) | 皮膚抗菌性組成物 | |
WO2021261824A1 (fr) | Composition cosmétique cationique permettant de faire adhérer le maquillage et d'empêcher que ce dernier ne parte | |
JP2010235489A (ja) | 含水化粧料 | |
JP4326689B2 (ja) | プラスミノーゲンアクチベーター阻害剤およびそれを配合した皮膚外用剤 | |
JPH1180588A (ja) | 表面処理粉体及びそれを含有して成る化粧料 | |
JPS6327414A (ja) | 皮膚外用剤 | |
WO2018128189A1 (fr) | Particule de protection contre les ultraviolets revêtue d'oxyde de silicium, composition aqueuse contenant des particules de protection contre les ultraviolets revêtues d'oxyde de silicium, et produit cosmétique | |
WO2012067308A1 (fr) | Particules composites à base d'oxyde de zinc/dioxyde de titane et leur procédé de préparation | |
JPH10194929A (ja) | 化粧料用抗菌性顔料、前記顔料の製造方法及び前記顔料を含有する化粧料組成物 | |
EP0890356A2 (fr) | Poudres enrobees pour produits protecteurs contre les rayons uv | |
JP2978303B2 (ja) | 化粧料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18823951 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 3068205 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18823951 Country of ref document: EP Kind code of ref document: A2 |